Rankings
▼
Calendar
EYPT Q1 2023 Earnings — EyePoint Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
EYPT
EyePoint Pharmaceuticals, Inc.
$1B
Q1 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$8M
-17.3% YoY
Gross Profit
$7M
91.7% margin
Operating Income
-$22M
-280.5% margin
Net Income
-$21M
-275.5% margin
EPS (Diluted)
$-0.58
QoQ Revenue Growth
-27.1%
Cash Flow
Operating Cash Flow
-$17M
Free Cash Flow
-$17M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$155M
Total Liabilities
$76M
Stockholders' Equity
$78M
Cash & Equivalents
$106M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$8M
$9M
-17.3%
Gross Profit
$7M
$8M
-6.3%
Operating Income
-$22M
-$18M
-17.9%
Net Income
-$21M
-$21M
-0.9%
Revenue Segments
Product
$7M
96%
Royalty
$255,000
3%
License And Collaboration Agreement
$34,000
0%
← FY 2023
All Quarters
Q2 2023 →